Navigation Links
Exercise Activities Helps To Avoid Heart Ailment

A new research has stated that it's never too late for a person to start exercising for cutting down their risk of heart disease.//

The researchers particularly taking into consideration the people who were of the habit of being 'couch potatoes' explained that the exercise need not be of any strenuous nature but rather even simple measures like walking could make the difference. Dr Dietrich Rothenbacher, an epidemiologist at the University of Heidelberg in Germany said, "You don't have to go to the gym. Just get off the couch. It is never too late to start exercising."

The researchers based their study on the effect of physical activity on patients with coronary heart disease (CHD) and with a group of healthy volunteers who were of the same age and sex. The found that among those people who exercised a lot throughout their life had a reduced risk of the illness that is one of the biggest killers in the industrial countries.

Dr Rothenbacher said, "But we also found that people who changed their physical activity patterns in late adult life also reduced their risk for coronary heart disease." The scientist's had also re-evaluated the data that they had previously collected on patients and volunteers of the age group 40 to 68 who had already been questioned on their habits and exercise patterns.

It was explained that smoking, diabetes and high blood pressure, are all risk factors for heart disease, which were more common in the patients with the illness than in the healthy volunteers. The researchers explained that people who had been active throughout their lives had about a 60% reduced risk of being diagnosed with coronary heart disease. And that the couch potatoes who had changed their ways and had started exercising even after the age of 40 were about 55% less likely to be diagnosed with the illness than people who had always been and are still inactive.

Rothenbacher, in the study published in the journa
'"/>




Page: 1 2

Related medicine news :

1. Exercises reduce risks of cancers
2. Exercise lowers Risk of Ovarian Cancer
3. Exercise is necessary in daily life
4. Exercise for patients with cancer
5. Exercise therapy for fibromyalgia
6. Exercise has a undeniable effect on cholesterol
7. Exercise with music aids with lung disorders
8. Exercise helps with leg cramps
9. Exercise helps people with cramping leg pain
10. Kids not getting enough Physical Exercise
11. Moderate Exercise may not help prevent Heart Disease

Post Your Comments:
(Date:11/8/2009)...aises House Passage of Health Care Reform Bill ,...e, improve coverage for all Americans ,, CHICA...nited States House of Representatives passed by a ...lation that would strengthen Medicare for seniors ... prices millions of Americans out of affordable he...
(Date:11/8/2009)...aises House Passage of Health Care Reform Bill ,...e, improve coverage for all Americans ,, BALTI... Tonight the United States House of Representative...hat would strengthen Medicare for seniors and end ...millions of Americans out of affordable health cov...
(Date:11/7/2009)...ON, Nov. 7 Karen Ignagn... Plans (AHIP), released the following statement to...lans strongly support comprehensive health care re...y proposing a complete overhaul of how health insu...guaranteed coverage, elimination of pre-existing c...
(Date:11/7/2009)... Nov. 7, The American M...njamin Rush Award for Citizenship and Community Se...from Chicago, IL. The award recognizes physicians ...call of duty to make an outstanding public service...received the award today during the opening sessio...
(Date:11/7/2009)...yn T. Coleman (CT), David A. Cook (GA), Louis J. G... (LA) Honored ,, CHICAGO, Nov. 7 /PRNewswire-U...A) today presented five medical society executive ...tributions to the goals and ideals of the medical ... semi-annual policy making meeting in Houston. ,...
Breaking Medicine News(10 mins):Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2Health News:AMA Honors Medical Society Executives 2
...he Prescription Drug User Fee Act (PDUFA) user fee...ry 18, 2008 -, YARDLEY, Pa., Sept. 20 Tibotec Ph...ug Application (NDA) for TMC125,(etravirine), an i...stration (FDA). The Prescription Drug User Fee,Act...
...LIN, N.J., Sept. 20 SyntheMed, Inc. (OTC,Bulletin...he development,and commercialization of anti-adhes...t the Circulatory System Devices Advisory Panel of...,likely to need secondary open heart surgery. The ...
...phyX(TM) receives FDA clearance, REDMOND, Wash., ... EsophyX(TM) device for performing Transoral Incis...ing gastroesophageal reflux,disease has received F...pleted yesterday under general anesthesia,transora...
...BOSTON Since the days of Hippocrates, people have ...seasons. More recently, researchers have learned t...seasonality, are often related to the weather. In ... Department of Public Heath and Family Medicine at...
...(Washington) Expressions of deep concern and disa...authorization will go forward without addressing s...for Medicare beneficiaries were sent today to cong...nal medicine physicians and medical student member...
...ndation Duped By Overseas Supplier, WAKEFIELD, Ma...tion established to support cancer-fighting resear...ng due to high lead levels the jewelry it,distribu... contain lead. When Friends of Mel recently learne...
Other Medicine News:Health News:FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125 2Health News:FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125 3Health News:FDA Panel Recommends Approval of SyntheMed's REPEL-CV(R) Adhesion Barrier for Pediatric Patients 2Health News:The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers 2Health News:The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers 3Health News:The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers 4Health News:Mathematics might save you a trip to the ER 2Health News:'Deep concern and disappointment' with exclusion of Medicare from SCHIP legislation 2Health News:'Deep concern and disappointment' with exclusion of Medicare from SCHIP legislation 3Health News:Friends of Mel Announce Recall of Jewelry Due to Lead 2Health News:Friends of Mel Announce Recall of Jewelry Due to Lead 3
(Date:11/6/2009)..., Nov. 6 Caraco Pharmace...aunched ketorolac tromethamine ophthalmic solution... and Drug Administration (FDA) for Sun Pharma,s Ab...Acular® opthalmic solution on the first day f...olac is therapeutically equivalent to Acular®...
(Date:11/6/2009)...IS, November 6 , - Trial ...lid for the,Treatment of Multi-Resistant Staphyloc... a speciality pharmaceutical company focused on th...esigned to overcome the significant global,problem... most advanced oral,antibacterial NXL103 (floprist...
(Date:11/5/2009)...GO, Nov. 5 Althea Technologies, I...turing services for biopharmaceutical products ann...lopment to the company,s platform of services, whi...es Matsuura, Director of Formulation Development. ...ion and analytical scientists, along with new labo...
Breaking Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2Partnership to accelerate Trudeau Institute discoveries to patient care 8711 1Partnership to accelerate Trudeau Institute discoveries to patient care 8711 2Kidnapped Nonviolent Peaceforce Civilian Peacekeeper Released Unharmed 47816 1Kidnapped Nonviolent Peaceforce Civilian Peacekeeper Released Unharmed 47816 2Kidnapped Nonviolent Peaceforce Civilian Peacekeeper Released Unharmed 47816 3WWII Veterans Compete in National Veterans Golden Age Games 47813 1WWII Veterans Compete in National Veterans Golden Age Games 47813 2
...NTA, Dec. 11 The Arthritis Foundation,the leading...llion,Americans living with arthritis, today annou...eters of Enbrel (R) (etanercept), will be the,nati... (R)., "The Arthritis Foundation hosts hundreds o...to prevent, control and cure arthritis, the,nation...
...CETON, N.J. and FOSTER CITY, Calif., Dec. 11 /PRNe...(NYSE: BMY ) and Gilead Sciences, Inc.,(Nasdaq: ...ze ATRIPLA(R),(efavirenz 600 mg/emtricitabine 200 ... for the treatment of virologically suppressed adu... approval by the European,Commission. If approved,...
Other Medicine Technology:Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R) 2Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R) 3Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R) 4Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 2Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 3Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 4Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 5Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 6Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 7Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 8
Assay Development
Custom Conjugation
Iso-Electric Determination Kit
Rabbit Anti-Goat IgG (H & L) Antibody, Colloidal Gold Conjugated, 50 OD
Medicine Products: